These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 22679906

  • 1. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.
    Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM.
    Liver Int; 2012 Oct; 32(9):1407-14. PubMed ID: 22679906
    [Abstract] [Full Text] [Related]

  • 2. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH.
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [Abstract] [Full Text] [Related]

  • 3. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group.
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [Abstract] [Full Text] [Related]

  • 4. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG.
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [Abstract] [Full Text] [Related]

  • 5. Prognostic markers in patients with cirrhosis and portal hypertension who have not bled.
    Poca M, Puente A, Graupera I, Villanueva C.
    Dis Markers; 2011 Feb; 31(3):147-54. PubMed ID: 22045400
    [Abstract] [Full Text] [Related]

  • 6. Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes.
    Garcia-Guix M, Ardevol A, Sapena V, Alvarado-Tápias E, Huertas A, Brujats A, Fajardo J, Cuyas B, Poca M, Guarner C, Torras X, Escorsell À, Villanueva C.
    Liver Int; 2024 Aug; 44(8):1971-1989. PubMed ID: 38634685
    [Abstract] [Full Text] [Related]

  • 7. Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.
    Turco L, Garcia-Tsao G, Magnani I, Bianchini M, Costetti M, Caporali C, Colopi S, Simonini E, De Maria N, Banchelli F, Rossi R, Villa E, Schepis F.
    J Hepatol; 2018 May; 68(5):949-958. PubMed ID: 29331339
    [Abstract] [Full Text] [Related]

  • 8. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J, Iwakiri Y.
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [Abstract] [Full Text] [Related]

  • 9. Classification of cirrhosis: the clinical use of HVPG measurements.
    Albilllos A, Garcia-Tsao G.
    Dis Markers; 2011 Feb; 31(3):121-8. PubMed ID: 22045397
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis.
    Kim TY, Lee JG, Sohn JH, Kim JY, Kim SM, Kim J, Jeong WK.
    Yonsei Med J; 2016 Jan; 57(1):138-45. PubMed ID: 26632394
    [Abstract] [Full Text] [Related]

  • 13. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A.
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [Abstract] [Full Text] [Related]

  • 14. Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis.
    Ripoll C, Lastra P, Rincón D, Catalina V, Bañares R.
    Scand J Gastroenterol; 2012 Feb; 47(2):204-11. PubMed ID: 22242615
    [Abstract] [Full Text] [Related]

  • 15. Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis.
    Alvarado-Tapias E, Ardevol A, Garcia-Guix M, Montañés R, Pavel O, Cuyas B, Graupera I, Brujats A, Vilades D, Colomo A, Poca M, Torras X, Guarner C, Concepción M, Aracil C, Torres F, Villanueva C.
    J Hepatol; 2020 Oct; 73(4):829-841. PubMed ID: 32298768
    [Abstract] [Full Text] [Related]

  • 16. Clinical Evaluation and Prognosis.
    Hernández-Gea V, Berzigotti A.
    Dig Dis; 2015 Oct; 33(4):515-23. PubMed ID: 26159268
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum Albumin Can Identify Patients With Compensated Cirrhosis With a Good Prognosis.
    Ripoll C, Bari K, Garcia-Tsao G.
    J Clin Gastroenterol; 2015 Aug; 49(7):613-9. PubMed ID: 25203362
    [Abstract] [Full Text] [Related]

  • 19. Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices.
    Lee E, Kim YJ, Goo DE, Yang SB, Kim HJ, Jang JY, Jeong SW.
    World J Gastroenterol; 2016 Mar 21; 22(11):3212-9. PubMed ID: 27003998
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D, Lo Iacono O, Tejedor M, Hernando A, Ripoll C, Catalina MV, Salcedo M, Matilla A, Senosiain M, Clemente G, Molinero LM, Albillos A, Bañares R.
    Scand J Gastroenterol; 2013 Apr 21; 48(4):487-95. PubMed ID: 22871085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.